CCL26 and nasal cavity polyp: The strong induction of eotaxin-3 from nasal tissue, high levels of eotaxin-3 in nasal polyp (36), and its expression of endothelial cells (15) could keep the plasma high levels of eotaxin-3 in the patients with ECRS.